Enduring Material

MASH Unlocked: Diagnostics and the New Therapeutic Era
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
Colorado Medical Society

7351 Lowry Blvd, Suite 110
Denver, CO 80230-6902
General Information
Monday, July 13, 2026 - Friday, October 1, 2027
60 minutes
SC Liver Research Consortium
Virtual Conference Room
MASH Unlocked: Diagnostics and the New Therapeutic Era
Colorado Medical Society
Objectives
  • Apply updated MASLD/MASH nomenclature and noninvasive diagnostic algorithms to accurately identify and risk-stratify patients, leading to earlier intervention and appropriate referral.
  • Incorporate clinical trial data and FDA-approved and emerging therapies into individualized treatment plans for patients with MASH to improve fibrosis-related outcomes.
  • Implement practical, patient-centered management strategies; including metabolic risk modification and long-term monitoring; to optimize adherence and real-world treatment effectiveness.
Presentations and Speakers
  • Shaun Chandna, DO, FACP, AGAF - Olive View-UCLA Medical Center
Available Credits/Points
  • The Colorado Medical Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Colorado Medical Society designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Speakers:
Shaun Chandna, DO, FACP, AGAF has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Mirum Pharmaceuticals - Consulting - Relationship Has Not Ended
  • Madrigal Pharmaceuticals - Consulting - Relationship Ended
  • Ipsen - Consulting - Relationship Ended
  • Madrigal Pharmaceuticals - Speakers Bureau - Relationship Has Not Ended
  • Gilead Sciences - Speakers Bureau - Relationship Has Not Ended
Any financial relationship that was found to be relevant has been mitigated.

Planners and other Administrative Support:
Paul J. Pockros, MD, Hepatology has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Gilead - Speakers Bureau - Relationship Has Not Ended
  • Gilead - Advisory Committee Member - Relationship Has Not Ended
  • Ipsen - Speakers Bureau - Relationship Has Not Ended
  • Ipsen - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Speakers Bureau - Relationship Has Not Ended
  • Novo - Speakers Bureau - Relationship Has Not Ended
  • Mirum - Consulting - Relationship Has Not Ended
  • Intercept - Consulting - Relationship Ended
  • Orphalan - Advisory Committee Member - Relationship Has Not Ended
  • Boston Pharmaceuticals - Review Panel Member - Relationship Ended
  • f5 Therapeutics - Board Member - Relationship Has Not Ended
Shaun Chandna, DO, FACP, AGAF has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Mirum Pharmaceuticals - Consulting - Relationship Has Not Ended
  • Madrigal Pharmaceuticals - Consulting - Relationship Ended
  • Ipsen - Consulting - Relationship Ended
  • Madrigal Pharmaceuticals - Speakers Bureau - Relationship Has Not Ended
  • Gilead Sciences - Speakers Bureau - Relationship Has Not Ended

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and the SC Liver Research Consortium The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Test Information
100 %
100 %
7/7/2026
Continue to Enduring Material